Plasma isocitrate dehydrogenase as a marker of centrilobular hepatic necrosis in patients with hyperthyroidism

Y H Chung1, S A Jung, B C Song

  • 1Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Insights

Plasma Isocitrate dehydrogenase (ICDH) levels and ICDH/ALT ratios are elevated in hyperthyroidism patients, suggesting ICDH may help monitor liver necrosis. This finding aids in distinguishing liver injury types.

Area of Science:

  • Biochemistry
  • Hepatology
  • Endocrinology

Background:

  • Liver injury can manifest as centrilobular or periportal necrosis.
  • Isocitrate dehydrogenase (ICDH) has shown potential in differentiating these patterns in animal models.
  • Hyperthyroidism can be associated with liver dysfunction.

Purpose of the Study:

  • To evaluate plasma ICDH as a marker for centrilobular necrosis in hyperthyroid patients.
  • To compare ICDH and alanine aminotransferase (ALT) levels in hyperthyroidism, chronic viral hepatitis (CVH), and controls.
  • To assess the utility of the ICDH/ALT ratio in diagnosing liver injury in hyperthyroidism.

Main Methods:

  • Measured plasma ICDH and ALT activities in 56 hyperthyroid patients, 16 CVH patients, and 17 controls.
  • Analyzed differences in enzyme levels and ratios between groups.
  • Correlated ICDH and ALT levels within patient cohorts.

Main Results:

  • Plasma ICDH levels were significantly higher in hyperthyroid patients compared to CVH patients and controls (p < 0.01 and p < 0.001).
  • ALT levels were higher in CVH patients than in hyperthyroid patients (p < 0.01).
  • The ICDH/ALT ratio was significantly higher in hyperthyroid patients than in CVH patients (p < 0.0001).
  • ICDH levels decreased to normal as thyroid function and ALT normalized in a hyperthyroid patient.

Conclusions:

  • Plasma ICDH and the ICDH/ALT ratio may serve as valuable biomarkers for identifying and monitoring hepatic necrosis in hyperthyroidism.
  • These markers could aid in differentiating centrilobular from periportal necrosis.
  • Further research is warranted to confirm these findings in larger patient cohorts.

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...